Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03739931
Title Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Patients With Advanced Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Moderna Therapeutics
Indications

Advanced Solid Tumor

lymphoma

Therapies

mRNA-2752

mRNA-2752 + Tremelimumab

Durvalumab + mRNA-2752

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.